South and Central America Closed Systems Drug Transfer Devices Market Growth Drivers by 2027

The South & Central America closed systems drug transfer devices market is expected to reach US$ 118.49 million by 2027 from US$ 28.37 million in 2019; it is expected to grow at a CAGR of 19.6% from 2019 to 2027.

Driving factors include growing adoption of chemotherapy and improvement of regulatory guidelines regarding hazardous drugs. However, the lack of regulatory guidelines regarding health workers’ safety in emerging countries may restrain the market growth.

The closed system drug transfer devices provide protection against hazardous drugs or vapors during drug preparation and administration. It comprises components which enables filtering of dangerous vapors out of the system. Closed system drug transfer devices play a major role in protection of healthcare professionals from antineoplastic as well as other harmful medications. Growing emphasis on implementation of occupational health and safety standards by government authorities are offering lucrative opportunity for growth of the market.

Chemotherapy is one of the prominent cancer treatment procedures accepted all over South & Central America. With growing number of R&D activities in cancer and its treatment, many healthcare players are developing new chemotherapeutic agents and gaining FDA approvals for the same. For instance, till 2018, FDA approved 19 lung cancer drugs, 14 of which were registered in Brazil. Around 80% (11 in 14) of lung cancer drugs approved in Brazil were available in Brazilian private setting and 14 % (2 in 14) in the public health system. Growing number of approvals for chemotherapeutic drugs, coupled with increasing prevalence of cancer, create lucrative opportunities for the future growth of the closed system drug transfer devices market players as these devices protect healthcare professionals from exposure to these harmful medications.

The COVID-19 pandemic has hit the South & Central America at a time when the region is already burdened with multiple problems, including a series of long-running conflicts, sectarian tension, economic crises, and widespread political unrest. Additionally, The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. Along with this many medical companies have shifted their focus of manufacturing from CSTD to respiratory devices. Such problems are likely to have a negative impact on the research and development activities, which will directly restrain the growth of the closed system drug transfer device (CSTD) market in the region.

Rest of South & Central America Closed Systems Drug Transfer Devices Market, Revenue and Forecast to
2027 (US$ Mn)

SOUTH & CENTRAL AMERICA CLOSED SYSTEMS DRUG TRANSFER DEVICES MARKET SEGMENTATION

By Closing Mechanism

• Push-to-turn Systems
• Luer-lock Systems
• Color-to-color Alignment Systems
• Click-to-lock Systems

By Type

• Membrane-to-membrane Systems
• Needleless Systems

By Technology

• Diaphragm-based Devices
• Compartmentalized Devices
• Air Cleaning/Filtration Devices

By Component

• Vial Access Devices
• Syringe Safety Devices
• Bag/Line Access Devices
• Accessories

By End User

• Hospitals and Clinics
• Oncology Centers
• Others

By Country

• Brazil
• Argentina
• Rest of South & Central America

Company Profiles

• B. Braun Medical Inc
• Victus, Inc
• BD
• EQUASHIELD
• ICU MEDICAL INC.

South and Central America Closed Systems Drug Transfer Devices Report Scope